CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 6 enrolled
Drug / intervention
Vigabatrin Only Productdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04772547
NCT04772547Phase 2Completed
CompareCT.gov

VIGABatrin in Post-anoxic STATus Epilepticus - Phase IIa

University of Florida·interventional·Posted Feb 26, 2021·Updated Jul 23, 2024

In Brief

A Phase 2 clinical trial evaluating Vigabatrin Only Product for Status Epilepticus, Electrographic and Coma. Completed, enrolled 6 participants across 1 site.

Detailed Summary

This is a pilot trial of a single loading dose of vigabatrin in post-anoxic status epilepticus.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStatus Epilepticus, Electrographic, Coma
CountriesUnited States
CollaboratorsYale University, Thomas Jefferson University, American Heart Association

Timeline

Phase 2CompletedFinished
20222023202420252026
First PostedFeb 26, 2021
Enrollment StartSep 22, 2021
Primary CompletionJun 7, 2023
Study CompletionJan 23, 2024
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 5.4 years ago

Interventions

Vigabatrin Only Productdrug

enteral medication administration, serial blood draws, and outcome assessment